FK506 independently upregulates transforming growth factor beta and downregulates inducible nitric oxide synthase in cultured human keratinocytes: possible mechanisms of how tacrolimus ointment interacts with atopic skin

The British Journal of Dermatology
C-C E LanG-S Chen

Abstract

Tacrolimus ointment (FK506) has been used in recent years for the treatment of atopic dermatitis (AD), with favourable results. Most of the therapeutic efficacy of FK506 in AD has been attributed to its immunomodulatory effects on different immune cell types, but its effects on keratinocytes (KCs) have rarely been discussed. Studies have shown that low expression of transforming growth factor (TGF)-beta and high expression of nitric oxide synthase (NOS) are implicated in the pathogenesis of AD. To investigate the direct effects of FK506 on KCs in terms of TGF-beta and inducible NOS (iNOS), and to explore the interactions between TGF-beta and iNOS in the KC system. Cultured human KCs treated with different concentrations of FK506 were used for investigation. The changes in the KC system induced by FK506 were documented in terms of TGF-beta and iNOS using enzyme-linked immunosorbent assay and Western blotting techniques, respectively. The gene expression of both TGF-beta and iNOS was also determined. A certain amount of tumour necrosis factor (TNF)-alpha was introduced to mimic atopic skin in vivo. Our results showed that the release of TGF-beta was upregulated in FK506-treated KCs, particularly in the presence of TNF-alpha, whil...Continue Reading

References

Apr 1, 1995·International Journal of Dermatology·H MoritaY Kitano
Mar 27, 1996·Biochemical and Biophysical Research Communications·I AranyS K Tyring
Jun 1, 2000·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·H J LeeJ W Kim
Jan 6, 2001·Journal of the American Academy of Dermatology·J M HanifinE Rafal
Jun 26, 2001·Allergy·S TaniuchiY Kobayashi
Aug 10, 2001·The Journal of Allergy and Clinical Immunology·P D ArkwrightI V Hutchinson

❮ Previous
Next ❯

Citations

Jun 15, 2006·Journal of Clinical Immunology·Marzia CaproniPaolo Fabbri
Feb 14, 2006·The Journal of Investigative Dermatology·Karin LoserStefan Beissert
Jan 24, 2006·International Immunopharmacology·K KisL Kemeny
Nov 14, 2008·Expert Opinion on Pharmacotherapy·Jan EhrchenMartin Steinhoff
Jun 13, 2008·The Journal of Allergy and Clinical Immunology·Bartlomiej KwiekNatalija Novak
Feb 22, 2018·Plastic and Reconstructive Surgery. Global Open·Bonnie C CarneyJeffrey W Shupp
May 30, 2013·Annals of Dermatology·Woo-Haing ShimMoon-Bum Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.